Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Table of Contents

PreviousNext

November 01 2009; volume 32 issue suppl 2

Introduction

  • You have accessRestricted Access
    Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)Dilemmas in clinical practice
    Itamar Raz
    Diabetes Care 2009 Nov; 32 (suppl 2): S149-S150. https://doi.org/10.2337/dc09-S300
    Add to Selected Citations

Diabetes Progression, Prevention, and Treatment

  • Progression/Prevention

    • You have accessRestricted Access
      Defining and Characterizing the Progression of Type 2 Diabetes
      Vivian A. Fonseca
      Diabetes Care 2009 Nov; 32 (suppl 2): S151-S156. https://doi.org/10.2337/dc09-S301
      Add to Selected Citations
    • You have accessRestricted Access
      Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
      Ralph A. DeFronzo and Devjit Tripathy
      Diabetes Care 2009 Nov; 32 (suppl 2): S157-S163. https://doi.org/10.2337/dc09-S302
      Add to Selected Citations
    • You have accessRestricted Access
      Viewpoints on the Way to a Consensus SessionWhere does insulin resistance start? The liver
      Gianluca Perseghin
      Diabetes Care 2009 Nov; 32 (suppl 2): S164-S167. https://doi.org/10.2337/dc09-S303
      Add to Selected Citations
    • You have accessRestricted Access
      Viewpoints on the Way to the Consensus SessionWhere does insulin resistance start? The adipose tissue
      Patricia Iozzo
      Diabetes Care 2009 Nov; 32 (suppl 2): S168-S173. https://doi.org/10.2337/dc09-S304
      Add to Selected Citations
    • You have accessRestricted Access
      Where Does Insulin Resistance Start?The brain
      Uberto Pagotto
      Diabetes Care 2009 Nov; 32 (suppl 2): S174-S177. https://doi.org/10.2337/dc09-S305
      Add to Selected Citations
    • You have accessRestricted Access
      Goals of Treatment for Type 2 Diabetesβ-Cell preservation for glycemic control
      Piero Marchetti, Roberto Lupi, Silvia Del Guerra, Marco Bugliani, Valentina D'Aleo, Margherita Occhipinti, Ugo Boggi, Lorella Marselli and Matilde Masini
      Diabetes Care 2009 Nov; 32 (suppl 2): S178-S183. https://doi.org/10.2337/dc09-S306
      Add to Selected Citations
    • You have accessRestricted Access
      Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 DiabetesPro pharmacologic therapy
      Alan J. Garber
      Diabetes Care 2009 Nov; 32 (suppl 2): S184-S188. https://doi.org/10.2337/dc09-S307
      Add to Selected Citations
    • You have accessRestricted Access
      Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
      Jaakko Tuomilehto
      Diabetes Care 2009 Nov; 32 (suppl 2): S189-S193. https://doi.org/10.2337/dc09-S308
      Add to Selected Citations
    • You have accessRestricted Access
      Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
      Muhammad A. Abdul-Ghani and Ralph A. DeFronzo
      Diabetes Care 2009 Nov; 32 (suppl 2): S194-S198. https://doi.org/10.2337/dc09-S309
      Add to Selected Citations
    • You have accessRestricted Access
      Target for Glycemic ControlConcentrating on glucose
      Louis Monnier and Claude Colette
      Diabetes Care 2009 Nov; 32 (suppl 2): S199-S204. https://doi.org/10.2337/dc09-S310
      Add to Selected Citations
    • You have accessRestricted Access
      Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
      Eleni I. Boutati and Sotirios A. Raptis
      Diabetes Care 2009 Nov; 32 (suppl 2): S205-S210. https://doi.org/10.2337/dc09-S312
      Add to Selected Citations
    • You have accessRestricted Access
      Telemedical Artificial PancreasPARIS (Páncreas Artificial Telemédico Inteligente) research project
      Alberto de Leiva, María Elena Hernando and on behalf of EDUAB-HSP and GBT-UPM
      Diabetes Care 2009 Nov; 32 (suppl 2): S211-S216. https://doi.org/10.2337/dc09-S313
      Add to Selected Citations
  • Treatment

    • You have accessRestricted Access
      Changing the Treatment Paradigm for Type 2 Diabetes
      Stefano Del Prato, Giuseppe Penno and Roberto Miccoli
      Diabetes Care 2009 Nov; 32 (suppl 2): S217-S222. https://doi.org/10.2337/dc09-S314
      Add to Selected Citations
    • You have accessRestricted Access
      Incretin-Based TherapiesViewpoints on the way to consensus
      Michael. A. Nauck, Tina Vilsbøll, Baptist Gallwitz, Alan Garber and Sten Madsbad
      Diabetes Care 2009 Nov; 32 (suppl 2): S223-S231. https://doi.org/10.2337/dc09-S315
      Add to Selected Citations
    • You have accessRestricted Access
      Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
      Antonio Ceriello and Roberto Testa
      Diabetes Care 2009 Nov; 32 (suppl 2): S232-S236. https://doi.org/10.2337/dc09-S316
      Add to Selected Citations
    • You have accessRestricted Access
      Bile Acids and Metabolic RegulationMechanisms and clinical responses to bile acid sequestration
      Bart Staels and Vivian A. Fonseca
      Diabetes Care 2009 Nov; 32 (suppl 2): S237-S245. https://doi.org/10.2337/dc09-S355
      Add to Selected Citations
    • You have accessRestricted Access
      β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
      Simona Cernea, Raffaella Buzzetti and Paolo Pozzilli
      Diabetes Care 2009 Nov; 32 (suppl 2): S246-S252. https://doi.org/10.2337/dc09-S317
      Add to Selected Citations
    • You have accessRestricted Access
      Insulin Therapy for Type 2 Diabetes
      Sanne G. Swinnen, Joost B. Hoekstra and J. Hans DeVries
      Diabetes Care 2009 Nov; 32 (suppl 2): S253-S259. https://doi.org/10.2337/dc09-S318
      Add to Selected Citations
    • You have accessRestricted Access
      Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic AgentsBasal or prandial insulin? The APOLLO trial and beyond
      Reinhard G. Bretzel, Michael Eckhard, Wolfgang Landgraf, David R. Owens and Thomas Linn
      Diabetes Care 2009 Nov; 32 (suppl 2): S260-S265. https://doi.org/10.2337/dc09-S319
      Add to Selected Citations
    • You have accessRestricted Access
      Early Insulin Treatment in Type 2 DiabetesWhat are the pros?
      Luigi F. Meneghini
      Diabetes Care 2009 Nov; 32 (suppl 2): S266-S269. https://doi.org/10.2337/dc09-S320
      Add to Selected Citations
    • You have accessRestricted Access
      Early Insulin Use in Type 2 DiabetesWhat are the cons?
      Jean-Louis Chiasson
      Diabetes Care 2009 Nov; 32 (suppl 2): S270-S274. https://doi.org/10.2337/dc09-S321
      Add to Selected Citations

Hypertension and Diabetes Debates

  • You have accessRestricted Access
    How to Define Prehypertension in Diabetes/Metabolic Syndrome
    Avshalom Leibowitz and Ehud Grossman
    Diabetes Care 2009 Nov; 32 (suppl 2): S275-S279. https://doi.org/10.2337/dc09-S323
    Add to Selected Citations
  • You have accessRestricted Access
    Should We Treat Prehypertension in Diabetes?What are the cons?
    Ehud Grossman
    Diabetes Care 2009 Nov; 32 (suppl 2): S280-S283. https://doi.org/10.2337/dc09-S324
    Add to Selected Citations
  • You have accessRestricted Access
    Treatment of Prehypertension in Diabetes and Metabolic SyndromeWhat are the pros?
    Julian Segura and Luis M. Ruilope
    Diabetes Care 2009 Nov; 32 (suppl 2): S284-S289. https://doi.org/10.2337/dc09-S325
    Add to Selected Citations
  • You have accessRestricted Access
    Hypertension and Diabetes: Should We Treat Early Surrogates?What are the cons?
    Peter M. Nilsson
    Diabetes Care 2009 Nov; 32 (suppl 2): S290-S293. https://doi.org/10.2337/dc09-S329
    Add to Selected Citations
  • You have accessRestricted Access
    Hypertension and DiabetesWhat are the pros to treating early surrogates?
    Roland E. Schmieder
    Diabetes Care 2009 Nov; 32 (suppl 2): S294-S297. https://doi.org/10.2337/dc09-S356
    Add to Selected Citations
  • You have accessRestricted Access
    Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
    Gianfranco Parati and Grzegorz Bilo
    Diabetes Care 2009 Nov; 32 (suppl 2): S298-S304. https://doi.org/10.2337/dc09-S326
    Add to Selected Citations
  • You have accessRestricted Access
    Should White-Coat Hypertension in Diabetes Be Treated? Pro
    Giuseppe Mancia, Roberto Sega, Michele Bombelli, Fosca Quarti-Trevano, Rita Facchetti and Guido Grassi
    Diabetes Care 2009 Nov; 32 (suppl 2): S305-S309. https://doi.org/10.2337/dc09-S327
    Add to Selected Citations
  • You have accessRestricted Access
    White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
    Michael Bursztyn and Iddo Z. Ben-Dov
    Diabetes Care 2009 Nov; 32 (suppl 2): S310-S313. https://doi.org/10.2337/dc09-S328
    Add to Selected Citations

Diabetes and Cardiovascular Disease

  • You have accessRestricted Access
    Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
    Daniele Versari, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni and Stefano Taddei
    Diabetes Care 2009 Nov; 32 (suppl 2): S314-S321. https://doi.org/10.2337/dc09-S330
    Add to Selected Citations
  • You have accessRestricted Access
    Implications of Postprandial Glucose and Weight Control in People With Type 2 DiabetesUnderstanding and implementing the International Diabetes Federation guidelines
    Baptist Gallwitz
    Diabetes Care 2009 Nov; 32 (suppl 2): S322-S325. https://doi.org/10.2337/dc09-S331
    Add to Selected Citations
  • You have accessRestricted Access
    The Munich Myocardial Infarction RegistryTranslating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
    Oliver Schnell, Wolfgang Otter and Eberhard Standl
    Diabetes Care 2009 Nov; 32 (suppl 2): S326-S330. https://doi.org/10.2337/dc09-S332
    Add to Selected Citations
  • You have accessRestricted Access
    Is Hyperglycemia a Causal Factor in Cardiovascular Disease?Does proving this relationship really matter? Yes
    Jaime A. Davidson and Christopher G. Parkin
    Diabetes Care 2009 Nov; 32 (suppl 2): S331-S333. https://doi.org/10.2337/dc09-S333
    Add to Selected Citations
  • You have accessRestricted Access
    Glucose Control and Cardiovascular DiseaseIs it important? No
    Ignacio Conget and Marga Giménez
    Diabetes Care 2009 Nov; 32 (suppl 2): S334-S336. https://doi.org/10.2337/dc09-S334
    Add to Selected Citations
  • You have accessRestricted Access
    Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
    Sameer A. Kassem and Itamar Raz
    Diabetes Care 2009 Nov; 32 (suppl 2): S337-S341. https://doi.org/10.2337/dc09-S335
    Add to Selected Citations
  • You have accessRestricted Access
    Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
    Cristina Bianchi, Roberto Miccoli, Giuseppe Daniele, Giuseppe Penno and Stefano Del Prato
    Diabetes Care 2009 Nov; 32 (suppl 2): S342-S348. https://doi.org/10.2337/dc09-S336
    Add to Selected Citations
  • You have accessRestricted Access
    Shifting the Disease Management Paradigm From GlucoseWhat are the pros?
    Alin Stirban, Diethelm Tschoepe and Bernd Stratmann
    Diabetes Care 2009 Nov; 32 (suppl 2): S349-S352. https://doi.org/10.2337/dc09-S337
    Add to Selected Citations
  • You have accessRestricted Access
    Shifting the Disease Management Paradigm From GlucoseWhat are the cons?
    Markolf Hanefeld, Stefan R. Bornstein and Frank Pistrosch
    Diabetes Care 2009 Nov; 32 (suppl 2): S353-S356. https://doi.org/10.2337/dc09-S338
    Add to Selected Citations
  • You have accessRestricted Access
    A Summary of the ADVANCE Trial
    Simon R. Heller and on behalf of the ADVANCE Collaborative Group*
    Diabetes Care 2009 Nov; 32 (suppl 2): S357-S361. https://doi.org/10.2337/dc09-S339
    Add to Selected Citations

Obesity and Lipids

  • You have accessRestricted Access
    Adipocytokines and Insulin ResistanceThe possible role of lipocalin-2, retinol binding protein-4, and adiponectin
    Eduardo Esteve, Wifredo Ricart and José Manuel Fernández-Real
    Diabetes Care 2009 Nov; 32 (suppl 2): S362-S367. https://doi.org/10.2337/dc09-S340
    Add to Selected Citations
  • You have accessRestricted Access
    Diabetes Surgery: A New Approach to an Old Disease
    Francesco Rubino, Tracy-Ann Moo, Daniel J. Rosen, Greg F. Dakin and Alfons Pomp
    Diabetes Care 2009 Nov; 32 (suppl 2): S368-S372. https://doi.org/10.2337/dc09-S341
    Add to Selected Citations
  • You have accessRestricted Access
    Triglycerides and HDL CholesterolStars or second leads in diabetes?
    Rafael Bitzur, Hofit Cohen, Yehuda Kamari, Aviv Shaish and Dror Harats
    Diabetes Care 2009 Nov; 32 (suppl 2): S373-S377. https://doi.org/10.2337/dc09-S343
    Add to Selected Citations
  • You have accessRestricted Access
    Should All Diabetic Patients Be Treated With a Statin?
    Yehuda Kamari, Rafael Bitzur, Hofit Cohen, Aviv Shaish and Dror Harats
    Diabetes Care 2009 Nov; 32 (suppl 2): S378-S383. https://doi.org/10.2337/dc09-S344
    Add to Selected Citations
  • You have accessRestricted Access
    American Diabetes Association Indications for Statins in DiabetesIs there evidence?
    Roy Eldor and Itamar Raz
    Diabetes Care 2009 Nov; 32 (suppl 2): S384-S391. https://doi.org/10.2337/dc09-S345
    Add to Selected Citations
  • You have accessRestricted Access
    Fat or Fit: What Is More Important?
    Vojtech Hainer, Hermann Toplak and Vladimír Stich
    Diabetes Care 2009 Nov; 32 (suppl 2): S392-S397. https://doi.org/10.2337/dc09-S346
    Add to Selected Citations
  • You have accessRestricted Access
    Obesity in Elderly SubjectsIn sheep's clothing perhaps, but still a wolf!
    Etty Osher and Naftali Stern
    Diabetes Care 2009 Nov; 32 (suppl 2): S398-S402. https://doi.org/10.2337/dc09-S347
    Add to Selected Citations
  • You have accessRestricted Access
    Obesity in the Elderly Diabetic PatientIs weight loss beneficial? No
    Ioannis Kyrou and Constantine Tsigos
    Diabetes Care 2009 Nov; 32 (suppl 2): S403-S409. https://doi.org/10.2337/dc09-S348
    Add to Selected Citations

Diagnosis and Treatment of Microvascular Disease

  • You have accessRestricted Access
    Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
    Mordchai Ravid
    Diabetes Care 2009 Nov; 32 (suppl 2): S410-S413. https://doi.org/10.2337/dc09-S349
    Add to Selected Citations
  • You have accessRestricted Access
    Painful Diabetic NeuropathyAdvantage of novel drugs over old drugs?
    Dan Ziegler
    Diabetes Care 2009 Nov; 32 (suppl 2): S414-S419. https://doi.org/10.2337/dc09-S350
    Add to Selected Citations
  • You have accessRestricted Access
    Microvascular Complications in Diabetic Erectile DysfunctionDo we need other alternatives?
    Yoram Vardi
    Diabetes Care 2009 Nov; 32 (suppl 2): S420-S422. https://doi.org/10.2337/dc09-S351
    Add to Selected Citations

Smoking

  • You have accessRestricted Access
    Smoking Cessation: It Is Never Too Late
    Peter M. Nilsson and Karl-Olov Fagerström
    Diabetes Care 2009 Nov; 32 (suppl 2): S423-S425. https://doi.org/10.2337/dc09-S352
    Add to Selected Citations
  • You have accessRestricted Access
    Why Won't Our Patients Stop Smoking?The power of nicotine addiction
    David M. Mannino
    Diabetes Care 2009 Nov; 32 (suppl 2): S426-S428. https://doi.org/10.2337/dc09-S353
    Add to Selected Citations
  • You have accessRestricted Access
    Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
    Robert H. Fagard
    Diabetes Care 2009 Nov; 32 (suppl 2): S429-S431. https://doi.org/10.2337/dc09-S354
    Add to Selected Citations
Back to top
PreviousNext

In this Issue

November 2009, 32(suppl 2)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)

Jump to

  • Introduction
  • Diabetes Progression, Prevention, and Treatment
    • Progression/Prevention
    • Treatment
  • Hypertension and Diabetes Debates
  • Diabetes and Cardiovascular Disease
  • Obesity and Lipids
  • Diagnosis and Treatment of Microvascular Disease
  • Smoking
  • Most Read
  • Most Cited
Loading
  • 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
  • 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
  • Table 1—Système International (SI) units for plasma, serum, or blood concentrations
  • 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
  • 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
More...

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.